Pacific Biosciences of California, Inc. (PACB) total debt

Total debt · fiscal 2025
$702.42M

Pacific Biosciences of California, Inc. (PACB) carried total debt of $702.42M at the end of fiscal 2025 (December 31, 2025). That is 4.5% higher than the $672.43M of fiscal 2024. Figures as of 18 Nov 2026, 04:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$702.42M
Change on fiscal 2024
+4.5%
Highest on record
$948.48Mfiscal 2022
Lowest on record
$2.79Mfiscal 2012
Fiscal years on record
142010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pacific Biosciences of California, Inc. total debt, in more detail

Across the 14 fiscal years on record (2010–2025), the highest was $948.48M in fiscal 2022 and the lowest $2.79M in fiscal 2012.

Total debt was 131.3× shareholders' equity at the end of fiscal 2025.

History · 14 fiscal years

Total debt by fiscal year

Pacific Biosciences of California, Inc. total debt, year by year

Pacific Biosciences of California, Inc. (PACB) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$702.42M 4.5% up131.3×
2024$672.43M 28.0% down1.3×
2023$933.93M 1.5% down1.3×
2022$948.48M 5.7% up1.7×
2021$897.68M—1.1×
2019$15.87M 8.3% up0.3×
2018$14.66M 7.5% up0.1×
2017$13.64M 15.3% down0.2×
2016$16.11M—0.2×
2014$14.12M 5.8% up0.3×
2013$13.35M 379.1% up0.2×
2012$2.79M 4.8% down0.0×
2011$2.93M 3.7% down0.0×
2010$3.04M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on PACB

Pacific Biosciences of California, Inc., figure by figure

Pacific Biosciences of California, Inc. (PACB) overview: price, valuation and scorecard

Pacific Biosciences of California, Inc. total debt: questions and answers

How much debt does Pacific Biosciences of California, Inc. have?

Pacific Biosciences of California, Inc. (PACB) carried total debt of $702.42M at the end of fiscal 2025 (December 31, 2025). That is 4.5% higher than the $672.43M of fiscal 2024.

What are the highest and lowest total debt figures on record for Pacific Biosciences of California, Inc.?

Across the 14 fiscal years on record (2010–2025), the highest was $948.48M in fiscal 2022 and the lowest $2.79M in fiscal 2012.

How does Pacific Biosciences of California, Inc.'s debt compare with its equity?

Total debt was 131.3× shareholders' equity at the end of fiscal 2025.

How is Pacific Biosciences of California, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pacific Biosciences of California, Inc. (PACB) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PACB/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.